KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Short-Term Debt issuances: 2010-2025

Historic Short-Term Debt issuances for National Health Investors (NHI) over the last 14 years, with Jun 2025 value amounting to $68.0 million.

  • National Health Investors' Short-Term Debt issuances rose 11.48% to $68.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $658.7 million, marking a year-over-year increase of 160.36%. This contributed to the annual value of $449.7 million for FY2024, which is 23.54% up from last year.
  • National Health Investors' Short-Term Debt issuances amounted to $68.0 million in Q2 2025, which was down 73.95% from $261.0 million recorded in Q1 2025.
  • National Health Investors' Short-Term Debt issuances' 5-year high stood at $261.0 million during Q1 2025, with a 5-year trough of $10.0 million in Q2 2022.
  • Moreover, its 3-year median value for Short-Term Debt issuances was $74.5 million (2023), whereas its average is $114.3 million.
  • As far as peak fluctuations go, National Health Investors' Short-Term Debt issuances slumped by 76.00% in 2021, and later surged by 342.37% in 2025.
  • Quarterly analysis of 5 years shows National Health Investors' Short-Term Debt issuances stood at $35.0 million in 2021, then soared by 100.00% to $60.0 million in 2022, then soared by 35.00% to $81.0 million in 2023, then surged by 153.95% to $205.7 million in 2024, then increased by 11.48% to $68.0 million in 2025.
  • Its last three reported values are $68.0 million in Q2 2025, $261.0 million for Q1 2025, and $205.7 million during Q4 2024.